\chapter*{Glossary}
\addcontentsline{toc}{chapter}{Glossary}

\footnotesize
\begin{longtable}[l]{l l}
    \textbf{AKT} & Protein Kinase B \\ 
    \textbf{ALK} & Anaplastic Lymphoma Kinase \\
    \textbf{AMP} & Association of Molecular Pathologists \\
    \textbf{BRAF} & V-Raf Murine Sarcoma Viral Oncogene Homolog B1 \\
    \textbf{CAP} & College of American Pathologists \\
    \textbf{CTLA-4} & Cytotoxic T-Lymphocyte-Associated Antigen 4 \\
    \textbf{EGFR} & Epidermal Growth Factor Receptor \\
    \textbf{EML4} & Echinoderm Microtubule-Associated Protein-Like 4 \\
    \textbf{ERRB} & Avian Erythroblastosis Oncogene B \\
    \textbf{ERK} & Extracellular Signal Regulated Kinase \\
    \textbf{GCO} & Global Cancer Observatory \\
    \textbf{HER2} & Human Epidermal Growth Factor Receptor 2 \\
    \textbf{IASLC} & International Association for the Study of Lung Cancer \\
    \textbf{JAK} & Janus Kinase \\
    \textbf{KRAS} & Kirsten Rat Sarcoma \\
    \textbf{MAPK} & Mitogen-Activated Protein Kinase \\
    \textbf{MEK} & Mitogen Activated Protein Kinase \\
    \textbf{MET} & Mesenchymal-to-Epithelial Transition \\
    \textbf{mTOR} & Mammalian Target of Rapamycin \\
    \textbf{NRG1} & Neuregulin 1 \\
    \textbf{NSCLC} & Non-Small Cell Lung Cancer \\
    \textbf{NTRK1} & Neurotrophic Tyrosine Kinase Receptor 1 \\
    \textbf{OS} & Overall Survival \\
    \textbf{PD-1} & Programmed Cell Death Protein 1 \\
    \textbf{PD-L1} & Programmed Death-Ligand 1 \\
    \textbf{PI3K} & Phosphoinositide 3-Kinase \\
    \textbf{RAF} & Rapidly Accelerated Fibrosarcoma \\
    \textbf{RAS} & Rat Sarcoma \\
    \textbf{RET} & Rearranged During Transfection \\
    \textbf{ROS} & Reactive Oxygen Species \\
    \textbf{ROS1} & Reactive Oxygen Species Proto-Oncogene 1 \\
    \textbf{SCLC} & Small Cell Lung Cancer \\
    \textbf{STAT} & Signal Transducer and Activator of Transcription Proteins \\
    \textbf{TKI} & Tyrosine Kinase Inhibitor \\
    \textbf{VATS} & Video-Assisted Thoracoscopic Surgery \\
    \textbf{VEGF} & Vascular Endothelial Growth Factor \\
    \textbf{VEGFR} & Vascular Endothelial Growth Factor Receptor \\
    \textbf{PFS} & Progression-Free Survival \\
    \textbf{RR} & Response Rate \\
    \textbf{PDGF} & Platelet-Derived Growth Factor \\
    \textbf{FGF} & Fibroblast Growth Factor \\
    \textbf{ALCL} & Anaplastic Large-Cell Lymphoma \\
    \textbf{NPM} & Nucleophosmin \\
    \textbf{NGS} & Next-Generation Sequencing \\
    \textbf{PCR} & Polymerase Chain Reaction \\
    \textbf{RT-PCR} & Reverse Transcription Polymerase Chain Reaction \\
    \textbf{FDA} & Food and Drug Administration \\
    \textbf{EMA} & European Medicines Agency \\
    \textbf{CNS} & Central Nervous System \\
    \textbf{BBB} & Blood-Brain Barrier \\
    \textbf{ORR} &  Overall Response Rate \\
    \textbf{IGF-1R} & Insulin-Like Growth Factor 1 Receptor \\
    \textbf{FISH} & Fluorescence in Situ Hybridization \\
    \textbf{IHC} & Immunohistochemistry \\
    \textbf{DNA} & Deoxyribonucleic Acid \\
    \textbf{RNA} & Ribonucleic Acid \\
    \textbf{CTC} & Circulating Tumor Cell \\
    \textbf{ctDNA} & Circulating Tumor DNA \\
    \textbf{TEP} & Tumor-Educated Platelet \\
    \textbf{EMT} & Epithelial–Mesenchymal Transition \\ 
    \textbf{MET} & Mesenchymal–Epithelial Transition \\
    \textbf{EpCAM} & Epithelial Cell Adhesion Molecule \\
    \textbf{cfDNA} & Circulating Free DNA \\
    \textbf{dPCR} & Digital Polymerase Chain Reaction \\
    \textbf{EV} & Extracellular Vesicle \\
    \textbf{mRNA} & Messenger RNA \\
\end{longtable}

\normalsize